Blue Bear Ventures | <a href="https://www.fiercebiotech.com/biotech/sarepta-to-pay-genedit-up-to-57m-near-term-for-non-viral-delivery-for-neuromuscular-gene">Sarepta rushes for GenEdit’s polymer nanoparticles in $57M gene editing delivery partnership

Posted at 01 Feb, 00:00h in News by alic 0 Comments

Sarepta Therapeutics will pay GenEdit up to $57 million in the near-term for access to the

Sarepta rushes for GenEdit’s polymer nanoparticles in $57M gene editing delivery partnership | Fierce Biotech